POWERING THE FUTURE OF MEDICINE Trademark

Trademark Overview


On Friday, February 2, 2024, a trademark application was filed for POWERING THE FUTURE OF MEDICINE with the United States Patent and Trademark Office. The USPTO has given the POWERING THE FUTURE OF MEDICINE trademark a serial number of 98388319. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Monday, March 31, 2025. This trademark is owned by Akron BioProducts, LLC. The POWERING THE FUTURE OF MEDICINE trademark is filed in the Chemical Products, Pharmaceutical Products, and Treatment & Processing of Materials Services categories with the following description:

Manufacture of materials to the order and specification of others for the cell and gene therapy industry; manufacturing of plasmid DNA, proteins and nucleases, growth media and buffers, and transfection and transduction reagents to the order and specification of others

Cytokines and growth factors in the nature of cell culture media for growing, conditioning or differentiating cells for medical or veterinary preparations, specifically in the form of a cell or gene therapy; human plasma-derived supplements, namely, blood plasma purified into proteins and converted into serums that are used in cell culture and formulation of cell and gene therapy products for medical purposes

Biological preparations and reagents for use in industry and science; biological preparations for use in cell cultures other than for medical or veterinary use; reagents for scientific and research use for chemical or biological analysis; plasmid DNA for use in the manufacture of viral vectors, mRNA, and other biologics, namely, biological preparations for use in industry and science; nucleases in the nature of cells for scientific and research purposes; cytokines in the nature of cells and biochemical reagents used in cell culture for scientific and research purposes; growth factors in the nature of cell growth media, and growth media supplemental for growing cells, for use in scientific research; cytokines and growth factors in the nature of cell culture media for growing, conditioning or differentiating cells for use in the manufacture of pharmaceuticals
powering the future of medicine

General Information


Serial Number98388319
Word MarkPOWERING THE FUTURE OF MEDICINE
Filing DateFriday, February 2, 2024
Status760 - EX PARTE APPEAL PENDING
Status DateMonday, March 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesManufacture of materials to the order and specification of others for the cell and gene therapy industry; manufacturing of plasmid DNA, proteins and nucleases, growth media and buffers, and transfection and transduction reagents to the order and specification of others
Goods and ServicesCytokines and growth factors in the nature of cell culture media for growing, conditioning or differentiating cells for medical or veterinary preparations, specifically in the form of a cell or gene therapy; human plasma-derived supplements, namely, blood plasma purified into proteins and converted into serums that are used in cell culture and formulation of cell and gene therapy products for medical purposes
Goods and ServicesBiological preparations and reagents for use in industry and science; biological preparations for use in cell cultures other than for medical or veterinary use; reagents for scientific and research use for chemical or biological analysis; plasmid DNA for use in the manufacture of viral vectors, mRNA, and other biologics, namely, biological preparations for use in industry and science; nucleases in the nature of cells for scientific and research purposes; cytokines in the nature of cells and biochemical reagents used in cell culture for scientific and research purposes; growth factors in the nature of cell growth media, and growth media supplemental for growing cells, for use in scientific research; cytokines and growth factors in the nature of cell culture media for growing, conditioning or differentiating cells for use in the manufacture of pharmaceuticals

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, March 1, 2024
Primary Code001
First Use Anywhere DateMonday, May 31, 2021
First Use In Commerce DateMonday, May 31, 2021

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 1, 2024
Primary Code005
First Use Anywhere DateMonday, May 31, 2021
First Use In Commerce DateMonday, May 31, 2021

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, March 1, 2024
Primary Code040
First Use Anywhere DateMonday, May 31, 2021
First Use In Commerce DateMonday, May 31, 2021

Trademark Owner History


Party NameAkron BioProducts, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBoca Raton, FL 33487

Trademark Events


Event DateEvent Description
Tuesday, February 6, 2024NEW APPLICATION ENTERED
Friday, March 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 27, 2024ASSIGNED TO EXAMINER
Wednesday, August 28, 2024NON-FINAL ACTION WRITTEN
Wednesday, August 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 28, 2024NON-FINAL ACTION E-MAILED
Friday, November 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 2, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, January 2, 2025FINAL REFUSAL WRITTEN
Thursday, January 30, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 2, 2025FINAL REFUSAL E-MAILED
Thursday, January 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 30, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 24, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 24, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 24, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 31, 2025EXPARTE APPEAL RECEIVED AT TTAB
Monday, March 31, 2025EX PARTE APPEAL-INSTITUTED
Monday, March 31, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY